Literature DB >> 16386831

Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters.

Yuichi Kuroiwa1, Akiyoshi Nishikawa, Yasuki Kitamura, Keita Kanki, Yuji Ishii, Takashi Umemura, Masao Hirose.   

Abstract

Potential chemopreventive effects of naturally occurring agents were investigated using a new 16-week medium-term pancreatic carcinogenesis models in hamsters. Male 6-week-old Syrian hamsters were subcutaneously injected with 10mg/kg body weight N-nitrosobis(2-oxopropyl)amine (BOP) four times within a week, and fed a diet supplemented with 80ppm benzyl isothiocyanate (BITC), 80ppm sulforaphane (SFN) or 10ppm resveratrol (RES) during the initiation or post-initiation stages. For the initiation stage, each chemical was given for 3 weeks including 1 week before and after the BOP injections. With post-initiation exposure, the groups were changed from basal diet 1 week after the last BOP injection, and then fed each chemical for 14 weeks. All the animals were sacrificed after 16 weeks. The multiplicities of combined pancreatic lesions including atypical hyperplasias and adenocarcinomas were significantly decreased by BITC and SFN given in the initiation but not the post-initiation stage. On the other hand, RES, a naturally occurring inhibitor of cyclooxygenase-2 (COX-2) reported chemopreventive effects, failed to show significant effects on pancreatic carcinogenesis in either the initiation or post-initiation stages. Our data suggest that the naturally occurring isothiocyanates BITC and SFN can block BOP-initiation of hamster pancreatic carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16386831     DOI: 10.1016/j.canlet.2005.10.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Sulforaphane as a Promising Natural Molecule for Cancer Prevention and Treatment.

Authors:  Osama A Elkashty; Simon D Tran
Journal:  Curr Med Sci       Date:  2021-04-20

Review 2.  Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research.

Authors:  Shivendra V Singh; Kamayani Singh
Journal:  Carcinogenesis       Date:  2012-06-27       Impact factor: 4.944

3.  Effects of 2-Phenethyl Isothiocyanate on Metabolism of 1,3-Butadiene in Smokers.

Authors:  Emily J Boldry; Jian-Min Yuan; Steven G Carmella; Renwei Wang; Katelyn Tessier; Dorothy K Hatsukami; Stephen S Hecht; Natalia Y Tretyakova
Journal:  Cancer Prev Res (Phila)       Date:  2019-11-26

4.  Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.

Authors:  Anuradha Sehrawat; Su-Hyeong Kim; Andreas Vogt; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2012-12-30       Impact factor: 4.944

Review 5.  Isothiocyanates: a class of bioactive metabolites with chemopreventive potential.

Authors:  Gaurav Kumar; Hardeep Singh Tuli; Sonam Mittal; Jitendra Kumar Shandilya; Anil Tiwari; Sardul Singh Sandhu
Journal:  Tumour Biol       Date:  2015-04-03

6.  A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.

Authors:  B Karthik Grandhi; Arvind Thakkar; Jeffrey Wang; Sunil Prabhu
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-26

7.  Novel strategies targeting cancer stem cells through phytochemicals and their analogs.

Authors:  Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul H Sarkar
Journal:  Drug Deliv Transl Res       Date:  2013-04-01       Impact factor: 4.617

Review 8.  Targeting NRF2 signaling for cancer chemoprevention.

Authors:  Mi-Kyoung Kwak; Thomas W Kensler
Journal:  Toxicol Appl Pharmacol       Date:  2009-09-02       Impact factor: 4.219

9.  Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implications for cancer prevention.

Authors:  Omkara L Veeranki; Arup Bhattacharya; James R Marshall; Yuesheng Zhang
Journal:  Br J Nutr       Date:  2012-04-02       Impact factor: 3.718

10.  Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.

Authors:  Young Bin Hong; Hyo Jin Kang; Hee Jeong Kim; Eliot M Rosen; Sivanesan Dakshanamurthy; Riccardo Rondanin; Riccardo Baruchello; Giuseppina Grisolia; Simoni Daniele; Insoo Bae
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.